Evidence map›Paper›PMID 40586327›Full record

ArticleEndocrine connections2025

Serum leptin and its relation to body composition, puberty, and metabolism in severe obesity.

Sabina Galiniak, Marek Biesiadecki, Rafał Podgórski, Natalia Dąbek, Ewa Gramatyka-Drążek, Ewelina Gaweł, Michael B Ranke, Bertram Flehmig, Martin Wabitsch, Stephanie Brandt and 6 more

Abstract read
In one paragraph

Article in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marek Biesiadecki
Natalia Dąbek
Ewa Gramatyka-Drążek
Ewelina Gaweł
Michael B Ranke
Bertram Flehmig
Martin Wabitsch
Stephanie Brandt
Elżbieta Petriczko
Małgorzata Wójcik
Ewa Małecka-Tendera
Mirosław Bik-Multanowski
Agnieszka Zachurzok
Artur Mazur

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Childhood severe obesity (SO) is a growing public health concern. Leptin (LEP) and its biologically active fraction (BioLEP) play a key role in energy balance and body mass regulation. Understanding their relationship with anthropometric and metabolic parameters is crucial for improving SO treatment. This study analyzed total LEP, BioLEP, and the BioLEP/LEP ratio in children with SO and their associations with body composition, lipid profile, and pubertal development. The study included 461 children (245 girls and 216 boys) aged 0-19 years with SO. Anthropometric parameters, metabolic indices, and pubertal stages (Tanner scale) were assessed. LEP and BioLEP concentrations were measured using ELISA, and the BioLEP/LEP ratio was calculated. The median LEP concentration was 56.53 ng/mL, and BioLEP was 53.66 ng/mL, with a BioLEP/LEP ratio of 0.94. Girls had significantly higher LEP (64.40 vs 49.66 ng/mL, P < 0.001) and BioLEP (59.90 vs 46.93 ng/mL, P < 0.001) than boys. LEP and BioLEP correlated positively with BMI, waist and hip circumference, and fat mass percentage, while negatively with waist-to-hip ratio and fat-free mass. The BioLEP/LEP ratio correlated positively with insulin and lipid profile parameters (total cholesterol, HDL, and triglycerides). LEP and BioLEP play a significant role in SO, particularly in fat mass regulation. The BioLEP/LEP ratio is more closely linked to lipid metabolism. These findings provide insights into the hormonal and metabolic profile of SO, supporting targeted diagnostic and therapeutic approaches.

Indexed as

biologically active leptinbody compositionleptinlipid profilesevere obesity

Identifiers

PMID40586327
PMCPMC12278361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.